Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation‐wide cohort study

The impact of diabetes for hepatocellular carcinoma (HCC) development in chronic hepatitis C (CHC) patients remains controversial.

[1]  C. la Vecchia,et al.  The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  H. Adami,et al.  Role of diabetes mellitus in the etiology of hepatocellular carcinoma. , 2000, Journal of the National Cancer Institute.

[3]  Jaw-Town Lin,et al.  Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection. , 2012, JAMA.

[4]  Qiwen Ben,et al.  Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta‐analysis of cohort studies , 2012, International journal of cancer.

[5]  P. Chou,et al.  Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. , 2007, American journal of epidemiology.

[6]  Ding‐Shinn Chen,et al.  Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  M. Abraham,et al.  Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis , 2012, Hepatology.

[8]  Pau-Chung Chen,et al.  Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Sheng-Nan Lu,et al.  Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV‐ and HCV‐endemic area of Southern Taiwan , 2013, The Kaohsiung journal of medical sciences.

[10]  F. Negro,et al.  Hepatitis C virus and glucose and lipid metabolism. , 2008, Diabetes & metabolism.

[11]  H. El‐Serag,et al.  The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[12]  Chien-Jen Chen,et al.  Hepatitis B e antigen and the risk of hepatocellular carcinoma. , 2002, The New England journal of medicine.

[13]  Chien-Jen Chen,et al.  Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. , 2008, Gastroenterology.

[14]  G. Farrell.  Insulin resistance, obesity, and liver cancer. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  Xilin Yang,et al.  Enhancers and attenuators of risk associations of chronic hepatitis B virus infection with hepatocellular carcinoma in type 2 diabetes. , 2013, Endocrine-related cancer.

[16]  M. Lai,et al.  Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection , 2006, Hepatology.

[17]  Keiji Tanaka,et al.  Involvement of the PA28γ-Dependent Pathway in Insulin Resistance Induced by Hepatitis C Virus Core Protein , 2006, Journal of Virology.

[18]  M. Nakagawa,et al.  Diabetes Mellitus May Be Associated with Hepatocarcinogenesis in Patients with Chronic Hepatitis C , 2002, Digestive Diseases and Sciences.

[19]  Yu-Hsuan Lin,et al.  Agreement between self-reported and health insurance claims on utilization of health care: A population study. , 2009, Journal of clinical epidemiology.

[20]  J. Goedert.  Infectious causes of cancer: targets for intervention. , 2000 .

[21]  Sutapa Banerjee,et al.  Hepatitis C Virus Core Protein Upregulates Serine Phosphorylation of Insulin Receptor Substrate-1 and Impairs the Downstream Akt/Protein Kinase B Signaling Pathway for Insulin Resistance , 2007, Journal of Virology.

[22]  F. Hu,et al.  The global implications of diabetes and cancer , 2014, The Lancet.

[23]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[24]  Chien-Jen Chen,et al.  Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study. , 2013, American journal of epidemiology.

[25]  Ching-Lan Cheng,et al.  Validation of the national health insurance research database with ischemic stroke cases in Taiwan , 2011, Pharmacoepidemiology and drug safety.

[26]  Alan D. Lopez,et al.  Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.

[27]  R. Loomba,et al.  Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non‐alcoholic fatty liver disease , 2012, Alimentary pharmacology & therapeutics.

[28]  Weiping Jia,et al.  Diabetes in Asia: epidemiology, risk factors, and pathophysiology. , 2009, JAMA.

[29]  N. Kato,et al.  Type 2 diabetes and hepatocellular carcinoma: A case–control study in patients with chronic hepatitis B , 2012, International journal of cancer.

[30]  Lu-Yu Hwang,et al.  Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus , 2002, Hepatology.

[31]  P. Chou,et al.  The Impact of Type 2 Diabetes on the Development of Hepatocellular Carcinoma in Different Viral Hepatitis Statuses , 2009, Cancer Epidemiology Biomarkers & Prevention.

[32]  V. Pazienza,et al.  The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype‐specific mechanisms , 2007, Hepatology.

[33]  Chien-Jen Chen,et al.  Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[34]  M. Sampson,et al.  Chromosomal telomere attrition as a mechanism for the increased risk of epithelial cancers and senescent phenotypes in type 2 diabetes , 2006, Diabetologia.

[35]  E. Bugianesi,et al.  Obesity and liver cancer. , 2014, Clinics in liver disease.

[36]  H. El‐Serag,et al.  Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. , 2004, Gastroenterology.

[37]  F. Negro,et al.  Current understanding of insulin resistance in hepatitis C , 2011, Expert review of gastroenterology & hepatology.

[38]  R O Morgan,et al.  Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study , 2005, Gut.

[39]  S-C Fu,et al.  Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study , 2015, Alimentary pharmacology & therapeutics.

[40]  D. Seidel,et al.  Systematic review: the association between obesity and hepatocellular carcinoma – epidemiological evidence , 2010, Alimentary pharmacology & therapeutics.

[41]  M. Manns,et al.  Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus , 2008, Hepatology.

[42]  D. Nelson,et al.  Review article: the management of hepatocellular carcinoma , 2010, Alimentary pharmacology & therapeutics.

[43]  Ding‐Shinn Chen,et al.  Overview of Hepatitis B and C Viruses , 2000 .

[44]  Sheng-Nan Lu,et al.  Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon‐based antiviral therapy , 2011, International journal of cancer.

[45]  J. Feld,et al.  Hepatitis C virus infection , 2015, Canadian Medical Association Journal.

[46]  Guan-Tarn Huang,et al.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. , 2006, JAMA.

[47]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .

[48]  Szu-Chieh Fu,et al.  Editorial: diabetes and its association with hepatocellular carcinoma in chronic hepatitis B – authors’ reply , 2015, Alimentary pharmacology & therapeutics.